Showing results (811-820 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA Oncology|May 30, 2020
Efficacy of Savolitinib vs Sunitinib in Patients With MET-Driven Papillary Renal Cell Carcinoma: The SAVOIR Phase 3 Randomized Clinical TrialToni K Choueiri, Daniel Y C Heng, Jae Lyun Lee, et al.
JAMA Oncology|May 6, 2021
Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell TransplantMichael Scordo, Trent P Wang, Kwang W Ahn, et al.
JAMA Oncology|June 5, 2020
Association of Reduced-Intensity Conditioning Regimens With Overall Survival Among Patients With Non-Hodgkin Lymphoma Undergoing Allogeneic TransplantNilanjan Ghosh, Sairah Ahmed, Kwang Woo Ahn, et al.
JAMA Oncology|April 17, 2020
Association of Utilization Management Policy With Uptake of Hypofractionated Radiotherapy Among Patients With Early-Stage Breast CancerRavi B Parikh, Ezra Fishman, Winnie Chi, et al.
JAMA Oncology|June 12, 2020
Clarification of Definitions of Hyperprogressive Disease During Immunotherapy for Non-Small Cell Lung CancerBaptiste Kas, Hugues Talbot, Roberto Ferrara, et al.
JAMA Oncology|May 15, 2020
Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter Phase 2 TrialShingo Miyamoto, Koichi Azuma, Hidenobu Ishii, et al.
JAMA Oncology|August 4, 2022
A New Approach to Simplifying and Harmonizing Cancer Clinical Trials-Standardizing Eligibility CriteriaDavid E Gerber, Harpreet Singh, Erin Larkins, et al.
JAMA Oncology|September 16, 2021
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging TrialThomas A Hope, Matthias Eiber, Wesley R Armstrong, et al.
JAMA Oncology|August 29, 2021
Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II): The Trans Tasman Radiation Oncology Group 13.01 Phase 2 Randomized Clinical TrialShankar Siva, Mathias Bressel, Tao Mai, et al.
JAMA Oncology|September 9, 2021
Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 Decades: A Blood or Marrow Transplant Survivor Study ReportSmita Bhatia, Chen Dai, Wendy Landier, et al.
Pageof 161